LINCOLN / NSE / Biotechnology & Drugs
Lincoln Pharmaceuticals
1Y Price Trend
Key Information
Recommendations
Target High770
Target Low439.95
Target Mean0
Target Median0
Risk Metrics
Overall RiskHigh risk
Board Risk53.38
Key Analysis
Overall score, performance score, return rating, defensive, aggressive, and balanced views.
Download appProjection Analytics
Best-case, base-case, worst-case, and dynamic AI projection views.
Download appLatest stock news
Broad-Based Technical Strength Lifts Lincoln Pharmaceuticals Ltd to 52-Week High of Rs 770 MarketsMojo
Lincoln Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicator Signals MarketsMojo
Lincoln Pharmaceuticals Ltd Technical Momentum Shifts Signal Bullish Outlook Markets Mojo
Number of shareholders of Lincoln Pharmaceuticals Ltd – BSE:LINCOLN TradingView
Lincoln Pharma Consolidated March 2026 Net Sales at Rs 187.28 crore, up 11.35% Y-o-Y Moneycontrol.com
Lincoln Pharma Consolidated March 2026 Net Sales at Rs 187.28 crore, up 11.35% Y-o-Y Moneycontrol.com
Lincoln Pharmaceuticals Ltd Technical Momentum Shifts Amid Market Volatility Markets Mojo
Lincoln Pharmaceuticals Ltd Shows Bullish Momentum Amid Technical Upgrades Markets Mojo
© SharekeyX | Rusaka Technologies 2024-2026

